218 related articles for article (PubMed ID: 29017215)
21. Recurrent Thrombi in an Obese Patient With History of Bariatric Surgery Despite Anti-Xa Therapy.
Briggler R; Matherne E; Johnson C; Boehmer K
J Pharm Pract; 2022 Oct; 35(5):811-816. PubMed ID: 33827312
[TBL] [Abstract][Full Text] [Related]
22. The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
Prandoni P; Barbar S; Milan M; Vedovetto V; Pesavento R
Eur J Intern Med; 2014 Jan; 25(1):25-30. PubMed ID: 24120221
[TBL] [Abstract][Full Text] [Related]
23. Recurrent thrombosis despite anticoagulation in a man with monocytosis. Case 8.
Bösiger J; Demarmels Biasiutti F
Hamostaseologie; 2003 Aug; 23(3):131-4. PubMed ID: 12923583
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of low-dose rivaroxaban in an 88-year-old female with pulmonary embolism: A case report.
Zhou H; Wei Q; Wu H; Tang M; Yang S; Liu Y; Qin L
Medicine (Baltimore); 2019 May; 98(20):e15705. PubMed ID: 31096518
[TBL] [Abstract][Full Text] [Related]
25. Oral rivaroxaban for symptomatic venous thromboembolism.
; Bauersachs R; Berkowitz SD; Brenner B; Buller HR; Decousus H; Gallus AS; Lensing AW; Misselwitz F; Prins MH; Raskob GE; Segers A; Verhamme P; Wells P; Agnelli G; Bounameaux H; Cohen A; Davidson BL; Piovella F; Schellong S
N Engl J Med; 2010 Dec; 363(26):2499-510. PubMed ID: 21128814
[TBL] [Abstract][Full Text] [Related]
26. Heparin-induced Thrombocytopenia Presenting With Deep Venous Thrombosis and Pulmonary Embolism Successfully Treated With Rivaroxaban: Clinical Case Report and Review of Current Experiences.
Samoš M; Bolek T; Ivanková J; Stančiaková L; Kovář F; Galajda P; Kubisz P; Staško J; Mokáň M
J Cardiovasc Pharmacol; 2016 Nov; 68(5):391-394. PubMed ID: 27464495
[TBL] [Abstract][Full Text] [Related]
27. Rivaroxaban in the treatment of venous thromboembolism and the prevention of recurrences: a practical approach.
Arcelus JI; Domènech P; Fernández-Capitan Mdel C; Guijarro R; Jiménez D; Jiménez S; Lozano FS; Monreal M; Nieto JA; Páramo JA
Clin Appl Thromb Hemost; 2015 May; 21(4):297-308. PubMed ID: 25504999
[TBL] [Abstract][Full Text] [Related]
28. Managing pulmonary embolism from presentation to extended treatment.
Cohen AT; Dobromirski M; Gurwith MM
Thromb Res; 2014 Feb; 133(2):139-48. PubMed ID: 24182642
[TBL] [Abstract][Full Text] [Related]
29. Rivaroxaban versus standard anticoagulation for symptomatic venous thromboembolism (REMOTEV observational study): Analysis of 6-month outcomes.
Gaertner S; Cordeanu EM; Nouri S; Faller AM; Frantz AS; Mirea C; Bilbault P; Ohlmann P; Le Ray I; Stephan D
Int J Cardiol; 2017 Jan; 226():103-109. PubMed ID: 27806307
[TBL] [Abstract][Full Text] [Related]
30. Acute pulmonary embolism treatment with rivaroxaban results in a shorter duration of hospitalisation compared to standard therapy: an academic centre experience.
Paczyńska M; Kurnicka K; Lichodziejewska B; Goliszek S; Dzikowska-Diduch O; Sobieraj P; Burzyński Ł; Kostrubiec M; Pruszczyk P; Ciurzyński M
Kardiol Pol; 2016; 74(7):650-6. PubMed ID: 26779849
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Venous Thromboembolism With New Anticoagulant Agents.
Becattini C; Agnelli G
J Am Coll Cardiol; 2016 Apr; 67(16):1941-55. PubMed ID: 27102510
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and Safety of Rivaroxaban in Patients with Venous Thromboembolism and Active Malignancy: A Single-Center Registry.
Bott-Kitslaar DM; Saadiq RA; McBane RD; Loprinzi CL; Ashrani AA; Ransone TR; Wolfgram AA; Berentsen MM; Wysokinski WE
Am J Med; 2016 Jun; 129(6):615-9. PubMed ID: 26797081
[TBL] [Abstract][Full Text] [Related]
33. Use of rivaroxaban in sickle cell disease and venous thromboembolism: A case report.
Rozi W; Ali EAH; Al-Mashdali AF; Abdelrazek M; Yassin MA
Medicine (Baltimore); 2021 Dec; 100(51):e27988. PubMed ID: 34941038
[TBL] [Abstract][Full Text] [Related]
34. Effective diagnosis and treatment of pulmonary embolism: Improving patient outcomes.
Meyer G
Arch Cardiovasc Dis; 2014; 107(6-7):406-14. PubMed ID: 25023859
[TBL] [Abstract][Full Text] [Related]
35. New oral anticoagulants for the treatment of venous thromboembolism.
Agnelli G; Becattini C; Franco L
Best Pract Res Clin Haematol; 2013 Jun; 26(2):151-61. PubMed ID: 23953903
[TBL] [Abstract][Full Text] [Related]
36. [Update on Current Care Guideline: Venous thromboembolism (VTE): deep venous thrombosis and pulmonary embolism].
Duodecim; 2016; 132(7):683-4. PubMed ID: 27188093
[TBL] [Abstract][Full Text] [Related]
37. Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience.
Arachchillage D; Reynolds R; Devey T; Maclean R; Kitchen S; van Veen JJ
Thromb Res; 2016 Nov; 147():32-35. PubMed ID: 27669125
[No Abstract] [Full Text] [Related]
38. Serpentine-like right atrial mass and fulminant bilateral pulmonary embolism during treatment with rivaroxaban.
Mayr A; Klug G; Greulich S; Metzler B; Feuchtner G
Int J Cardiovasc Imaging; 2016 Jun; 32(6):1001-2. PubMed ID: 26939567
[TBL] [Abstract][Full Text] [Related]
39. Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial.
Barco S; Lankeit M; Binder H; Schellong S; Christ M; Beyer-Westendorf J; Duerschmied D; Bauersachs R; Empen K; Held M; Schwaiblmair M; Fonseca C; Jiménez D; Becattini C; Quitzau K; Konstantinides S
Thromb Haemost; 2016 Jul; 116(1):191-7. PubMed ID: 27010343
[TBL] [Abstract][Full Text] [Related]
40. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
